Continued use of trastuzumab after progression in human epidermal growth factor receptor-2 positive breast cancer
10.3760/cma.j.issn.1674-6090.2016.02.002
- VernacularTitle:HER2阳性乳腺癌曲妥珠单抗初治病情进展后再应用探讨
- Author:
Haizhi LI
;
Zhengyan WU
- Publication Type:Journal Article
- Keywords:
Human epidermal growth factor receptor-2;
Trastuzumab;
Breast cancer;
Resistance
- From:
Chinese Journal of Endocrine Surgery
2016;10(2):104-105,134
- CountryChina
- Language:Chinese
-
Abstract:
This article reviews the cause of trastuzumab in treating human epidermal growth factor re-ceptor-2 (HER2) positive breast cancer, the evidence-based practice of continued use of trastuzumab, and some approaches to improve the efficacy of trastuzumab.
